Clinical Trials in Texas

Showing 12601-12620 of 12,973 trials

Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms

NCT00866411

The purpose of this double-blind randomized control research study is to determine if CES given in a group setting for soldiers experiencing irritability is effective to reduce the symptom of irritability.

Brooke Army Medical Center100 participantsStarted May 2007

Fort Hood, Texas, United States • Fort Sam Houston, Texas, United States

COMPLETEDPhase 355 miles

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

NCT00422123

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Affective Psychosis, BipolarManic DisorderManic-Depressive Psychosis+3 more

AstraZeneca447 participantsStarted Jan 2007

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Cerritos, California, United States +48 more locations

Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Find Trials by Condition in Texas

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Obese Patients With Type 2 Diabetes

Genetics of Fibromyalgia

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

Lofexidine for Inpatient Opiate Detox

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Prospective Evaluation of the Fluid Rapid Influenza Test

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder